METHOD FOR PREVENTING ONSET OF RESTENOSIS AFTER ANGIOPLASTY EMPLOYING A RETNOID
Summary: The present invention relates to a method for preventing onset of restenosis after angioplasty by administering a retinoid, which is preferably an agonist that is selective at the RAR receptor, i.e. a retinoid having a greater selectivity for the RAR receptor than the RXR receptor, or a pan agonist, i.e. a retinoid that may activate either the RAR or the RXR receptor.
NON-CONFIDENTIAL TECHNOLOGY DESCRIPTION
The preceding is intended to be a non-confidential summary of a novel technology created at the University of Texas Health Science center at Houston (UTHSCH), for which the University has obtained patent protection.
UTHSCH Ref. No. 1998-0004
Inventors: Drs. Peter Davies and Claude Benedict
Patent Status: United States Patent No. 5,798,372
License Available: world-wide; exclusive or non-exclusive
To obtain further information about this technology, please contact:
Office of Technology Management, 7000 Fannin, Suite 720, Houston, TX 77030
Phone: (713) 500-3369 Fax: (713) 500-0331
Email: uthsch-otm@uth.tmc.edu
